We are live on ! Find out more
RL

Ruffer LLP Portfolio holdings

AUM $2.83B
1-Year Est. Return 30.34%
This Fund
S&P 500
This Quarter Est. Return
-8.55%
1 Year Est. Return
+30.34%
3 Year Est. Return
+98.01%
5 Year Est. Return
+139.76%
10 Year Est. Return
+587.97%
AUM
$3.16B
AUM Growth
-$410M
Cap. Flow
-$33.1M
Cap. Flow %
-1.05%
Top 10 Hldgs %
64.23%
Holding
98
New
9
Increased
25
Reduced
29
Closed
8

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$115M
2
CI icon
Cigna
CI
+$76.9M
3
WPM icon
Wheaton Precious Metals
WPM
+$42.8M
4
CAR icon
Avis
CAR
+$40.3M
5
KGC icon
Kinross Gold
KGC
+$36.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.32%
2 Materials 22.81%
3 Financials 15.4%
4 Consumer Staples 10.93%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
1
Cigna
CI
$73.7B
$381M 12.07%
1,891,168
+353,754
+23% +$76.9M
ABEV icon
2
Ambev
ABEV
$48.1B
$306M 9.68%
110,784,545
+591,395
+0.5% +$1.87M
BMY icon
3
Bristol-Myers Squibb
BMY
$133B
$234M 7.4%
3,949,095
-300,178
-7% -$19.8M
KGC icon
4
Kinross Gold
KGC
$27.4B
$219M 6.93%
41,391,135
+6,080,481
+17% +$36.4M
CNC icon
5
Centene
CNC
$30.7B
$214M 6.77%
3,408,459
-2,048,070
-38% -$137M
WPM icon
6
Wheaton Precious Metals
WPM
$49.5B
$160M 5.06%
4,342,517
+980,707
+29% +$42.8M
EXE
7
Expand Energy Corp
EXE
$21.8B
$156M 4.94%
2,529,579
-65,365
-3% -$3.66M
AXP icon
8
American Express
AXP
$227B
$140M 4.43%
807,942
-255,265
-24% -$42.7M
AZN icon
9
AstraZeneca
AZN
$263B
$117M 3.7%
+985,898
New +$115M
FHI icon
10
Federated Hermes
FHI
$4.55B
$103M 3.25%
3,160,276
-35,526
-1% -$1.16M
EHTH icon
11
eHealth
EHTH
$42.2M
$88.9M 2.81%
2,156,575
+282,785
+15% +$13.2M
CTRA
12
DELISTED
Coterra Energy
CTRA
$80.2M 2.54%
3,621,149
+157,930
+5% +$2.71M
GM icon
13
General Motors
GM
$80.4B
$78M 2.47%
1,474,995
+137,067
+10% +$7.29M
AU icon
14
AngloGold Ashanti
AU
$40.1B
$68.5M 2.17%
4,245,122
+172,100
+4% +$2.98M
NOC icon
15
Northrop Grumman
NOC
$77.1B
$66.9M 2.12%
186,234
+9,319
+5% +$3.37M
XOM icon
16
ExxonMobil
XOM
$644B
$66.2M 2.1%
1,092,229
+124,433
+13% +$7.09M
SCHW
17
Charles Schwab
SCHW
$183B
$57.2M 1.81%
772,192
-10,738
-1% -$767K
CAR icon
18
Avis
CAR
$4.86B
$55.5M 1.76%
+457,636
New +$40.3M
GFI icon
19
Gold Fields
GFI
$29B
$55.1M 1.74%
6,767,015
+803,878
+13% +$7.19M
CGAU
20
Centerra Gold
CGAU
$3.36B
$42.5M 1.34%
6,079,550
+45,000
+0.7% +$333K
JPM icon
21
JPMorgan Chase
JPM
$935B
$38.5M 1.22%
231,431
-10,246
-4% -$1.61M
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.1T
$36.1M 1.14%
131,556
-12,304
-9% -$3.46M
NEM icon
23
Newmont
NEM
$98.7B
$36M 1.14%
676,154
+98,292
+17% +$5.8M
B
24
Barrick Mining
B
$61.5B
$34M 1.07%
1,900,597
+394,321
+26% +$7.92M
COTY icon
25
Coty
COTY
$2.42B
$29.6M 0.94%
3,637,910
+115,585
+3% +$989K

Similar funds

Ruffer LLP's Q3 2021 Portfolio in Review

As of Q3 2021, Ruffer LLP held 98 positions worth $3.16B, down 11% from $3.57B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ruffer LLP's Q3 2021 filing shows 9 new, 25 increased, 29 reduced and 8 closed positions. Its largest new stake was AstraZeneca: 985,898 shares worth $117M. The largest sale was Alexion Pharmaceuticals, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Materials and Financials.

  • Ruffer LLP's largest Q3 2021 buy was AstraZeneca: 985,898 shares worth $117M.
  • Ruffer LLP added most to Cigna in Q3 2021, an estimated $76.9M increase.
  • Ruffer LLP's biggest Q3 2021 reduction was Centene, cutting an estimated $137M.
  • Ruffer LLP fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $183M.
  • Ruffer LLP's ten largest holdings make up 64% of its $3.16B portfolio in Q3 2021.
  • Ruffer LLP opened 9 new positions and closed 8 in Q3 2021.
  • Ruffer LLP's portfolio value fell 11% quarter-over-quarter to $3.16B.

Based on Ruffer LLP's 13F filing for Q3 2021, filed 10 Nov 2021.